International Journal of Molecular Medical Science, 2025, Vol.15, No.6, 263-273 http://medscipublisher.com/index.php/ijmms 272 Mezzasoma L., Schmidt‐Weber C., and Fallarino F., 2023, In vitro study of TLR4-NLRP3-Inflammasome activation in innate immune response, Methods in Molecular Biology, 2700: 163-176. https://doi.org/10.1007/978-1-0716-3366-3_9 Mobeen A., Joshi S., Fatima F., Bhargav A., Arif Y., Faruq M., and Ramachandran S., 2025, NF-κB signaling is the major inflammatory pathway for inducing insulin resistance, 3 Biotech, 15(2): 47. https://doi.org/10.1007/s13205-024-04202-4 Mohammad S., and Thiemermann C., 2021, Role of metabolic endotoxemia in systemic inflammation and potential interventions, Frontiers in Immunology, 11: 594150. https://doi.org/10.3389/fimmu.2020.594150 Nozu T., and Okumura T., 2022, Pathophysiological commonality between irritable bowel syndrome and metabolic syndrome: role of corticotropin-releasing factor–toll-like receptor 4-proinflammatory cytokine signaling., Journal of Neurogastroenterology and Motility, 28: 173-184. https://doi.org/10.5056/jnm21002 Onu A., Trofin D., Tutu A., Onu I., Galaction A., Sardaru D., Trofin D., Onita C., Iordan D., and Matei D., 2025, Integrative strategies for preventing and managing metabolic syndrome: the impact of exercise and diet on oxidative stress reduction-a review, Life, 15(5): 757. https://doi.org/10.3390/life15050757 Park J., Kang E., and Han J., 2022, HM-chromanone attenuates TNF-α-mediated inflammation and insulin resistance by controlling JNK activation and NF-κB pathway in 3T3-L1 adipocytes, European Journal of Pharmacology, 921: 174884. https://doi.org/10.1016/j.ejphar.2022.174884 Rahimi G., Yousefabadi H., Niyazi A., Rahimi N., and Alikhajeh Y., 2021, Effects of lifestyle intervention on inflammatory markers and waist circumference in overweight/obese adults with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials, Biological Research For Nursing, 24: 94-105. https://doi.org/10.1177/10998004211044754 Ren Y., Zhao H., Yin C., Lan X., Wu L., Du X., Griffiths H., and Gao D., 2022, Adipokines hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation, Frontiers in Endocrinology, 13: 873699. https://doi.org/10.3389/fendo.2022.873699 Robison L., Gannon O., Thomas M., Salinero A., Abi-Ghanem C., Poitelon Y., Belin S., and Zuloaga K., 2020, Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer’s disease, Journal of Neuroinflammation, 17(1): 285. https://doi.org/10.1186/s12974-020-01956-5 Rossi J., Barbalho S., De Araújo R., Bechara M., Sloan K., and Sloan L., 2021, Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors, Diabetes/Metabolism Research and Reviews, 38(3): e3502. https://doi.org/10.1002/dmrr.3502 Roy P., Kant R., Kaur A., Kumar H., and Kumar R., 2025, Leptin resistance and cardiometabolic disorders: bridging molecular pathways genetic variants and therapeutic innovation, Current Cardiology Reviews, 21(5): e1573403X356019. https://doi.org/10.2174/011573403x356019250118170444 Saitoh S., Van Wijk K., and Nakajima O., 2021, Crosstalk between metabolic disorders and immune cells, International Journal of Molecular Sciences, 22(18): 10017. https://doi.org/10.3390/ijms221810017 Sandsdal R., Juhl C., Jensen S., Lundgren J., Janus C., Blond M., Rosenkilde M., Bogh A., Gliemann L., Jensen J., Antoniades C., Stallknecht B., Holst J., Madsbad S., and Torekov S., 2023, Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome abdominal obesity and inflammation: a randomized controlled trial, Cardiovascular Diabetology, 22(1): 41. https://doi.org/10.1186/s12933-023-01765-z Secchiero P., Rimondi E., Marcuzzi A., Longo G., Papi C., Manfredini M., Fields M., Caruso L., Di Caprio R., and Balato A., 2024, Metabolic syndrome and psoriasis: pivotal roles of chronic inflammation and gut microbiota, International Journal of Molecular Sciences, 25(15): 8098. https://doi.org/10.3390/ijms25158098 Silva N., Gonçalves R., Pascoal T., Lima-Filho R., Resende E., Vieira É., Teixeira A., De Souza L., Peny J., Fortuna J., Furigo I., Hashiguchi D., Miya-Coreixas V., Clarke J., Abisambra J., Longo B., Donato J., Fraser P., Rosa-Neto P., Caramelli P., Ferreira S., and De Felice F., 2021, Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease, Translational Psychiatry, 11(1): 251. https://doi.org/10.1038/s41398-021-01349-z Suárez-Cuenca J., Díaz-Jiménez D., Pineda-Juárez J., Mendoza-Mota A., Valencia-Aldana O., Núñez-Angeles S., Vera-Gómez E., Hernández-Patricio A., Loeza-Magaña P., Lara-Vargas J., Arteaga-Martínez J., Garduño-Pérez Á., Montoya-Ramírez J., Díaz-Aranda M., Chaparro-Hernández R., Melchor-López A., García S., Gutiérrez-Salinas J., and Mondragón‐Terán P., 2025, Effect of mediterranean diet in combination with isokinetic exercise therapy on body composition and cytokine profile in patients with metabolic syndrome, Nutrients, 17(2): 256. https://doi.org/10.3390/nu17020256 Sumerkina V., Telesheva L., and Golovneva E., 2022, Association of the cytokine profile and metabolic syndrome components in young patients, Russian Journal of Immunology, 25(4): 535-540. https://doi.org/10.46235/1028-7221-1164-aot Tylutka A., Morawin B., Walas Ł., Michałek M., Gwara A., and Zembron-Lacny A., 2023, Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults, Scientific Reports 13(1): 89.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==